If OpenAI (OPAI.PVT) is poised to unveil a device that's an Apple (AAPL) iPhone killer in 2026 to support its AI ambitions, Oura CEO Tom Hale thinks it could have a long way to go to drive mass appeal ...
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback